RegenMedTx Report issue

For profit Phase 1
Founded: Audubon PA United States (2003)
Status: Defunct (2018)

Organization Overview

First Clinical Trial
2013
NCT01846715
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Alternative names

Tengion, Inc.

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetes Mellitus, Type 2 (Phase 1)

Kidney Diseases (Phase 1)

Renal Insufficiency, Chronic (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 2
  • # of Trial APIs: 2